The Vioxx saga is not over yet. And a new court ruling may shed further light on the controversy over the Merck painkiller, which was withdrawn in 2004 over links to heart attacks and strokes. Last we…
Novartis has restarted producing one human overthecounter painkiller Excedrin and animal health antiparasitic drug Sentinel at its plant in Lincoln US.
And so, the Vioxx saga continues. Nearly eight years after Merck withdrew the controversial painkiller over links to heart attacks and strokes, a new paper indicates the drugmaker hid evidence that Vi…
OxyContin is set to go off patent next year, but the maker of the powerful and widely abused prescription painkiller is trying to extend its exclusive rights to the drug, arguing that a new version it…
